Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.47% | 131.02 | 0.0% | $2314.17m | |
| BNGO | BioNano Genomics, Inc. | 18.50% | 9.80 | 0.0% | $2016.46m | |
| GILD | Gilead Sciences, Inc. | -0.06% | 66.94 | 1.0% | $649.72m | |
| AMGN | Amgen, Inc. | 0.58% | 253.50 | 1.3% | $564.60m | |
| CRSP | CRISPR Therapeutics AG | 1.83% | 188.49 | 0.6% | $487.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.43% | 537.78 | 2.7% | $478.09m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.19% | 159.73 | 2.0% | $470.59m | |
| NVAX | Novavax, Inc. | 3.74% | 126.98 | 92.9% | $417.43m | |
| ILMN | Illumina, Inc. | 0.34% | 406.25 | 3.5% | $396.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.36% | 98.24 | 13.8% | $364.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.44% | 237.59 | 1.9% | $361.85m | |
| BIIB | Biogen, Inc. | -0.25% | 269.44 | 1.7% | $321.90m | |
| BNTX | BioNTech SE | 2.86% | 108.44 | 0.0% | $298.33m | |
| EXAS | EXACT Sciences Corp. | 1.30% | 150.00 | 19.6% | $243.95m | |
| PACB | Pacific Biosciences of California, Inc. | 3.06% | 37.42 | 7.4% | $228.17m |
Company Profile
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.